位置:首页 > 蛋白库 > KLC4_HUMAN
KLC4_HUMAN
ID   KLC4_HUMAN              Reviewed;         619 AA.
AC   Q9NSK0; B3KNY4; B3KPI3; B3KSQ3; B4DME9; Q66K28; Q96EG6;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   03-AUG-2022, entry version 187.
DE   RecName: Full=Kinesin light chain 4;
DE            Short=KLC 4;
DE   AltName: Full=Kinesin-like protein 8;
GN   Name=KLC4; Synonyms=KNSL8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 5), AND
RP   VARIANT HIS-72.
RC   TISSUE=Adrenal gland, Brain, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala, and Esophageal carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-590, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590 AND THR-612, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-590, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460; SER-566 AND SER-590, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Kinesin is a microtubule-associated force-producing protein
CC       that may play a role in organelle transport. The light chain may
CC       function in coupling of cargo to the heavy chain or in the modulation
CC       of its ATPase activity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Oligomeric complex composed of two heavy chains and two light
CC       chains. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NSK0; Q9P2A4: ABI3; NbExp=3; IntAct=EBI-949319, EBI-742038;
CC       Q9NSK0; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-949319, EBI-11752486;
CC       Q9NSK0; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-949319, EBI-10181988;
CC       Q9NSK0; Q9BW62: KATNAL1; NbExp=6; IntAct=EBI-949319, EBI-743591;
CC       Q9NSK0; A1A4E9: KRT13; NbExp=3; IntAct=EBI-949319, EBI-10171552;
CC       Q9NSK0; P19012: KRT15; NbExp=3; IntAct=EBI-949319, EBI-739566;
CC       Q9NSK0; P08779: KRT16; NbExp=3; IntAct=EBI-949319, EBI-356410;
CC       Q9NSK0; Q15323: KRT31; NbExp=6; IntAct=EBI-949319, EBI-948001;
CC       Q9NSK0; Q14525: KRT33B; NbExp=3; IntAct=EBI-949319, EBI-1049638;
CC       Q9NSK0; O76011: KRT34; NbExp=3; IntAct=EBI-949319, EBI-1047093;
CC       Q9NSK0; P50222: MEOX2; NbExp=3; IntAct=EBI-949319, EBI-748397;
CC       Q9NSK0; Q7Z6G3-2: NECAB2; NbExp=6; IntAct=EBI-949319, EBI-10172876;
CC       Q9NSK0; Q9UHV2: SERTAD1; NbExp=3; IntAct=EBI-949319, EBI-748601;
CC       Q9NSK0; Q7RTY1: SLC16A9; NbExp=3; IntAct=EBI-949319, EBI-10232636;
CC       Q9NSK0; Q8N205: SYNE4; NbExp=3; IntAct=EBI-949319, EBI-7131783;
CC       Q9NSK0; O75478: TADA2A; NbExp=3; IntAct=EBI-949319, EBI-742268;
CC       Q9NSK0; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-949319, EBI-739895;
CC       Q9NSK0; Q6P1L6: ZNF343; NbExp=3; IntAct=EBI-949319, EBI-10252492;
CC       Q9NSK0; P0DTC9: N; Xeno; NbExp=3; IntAct=EBI-949319, EBI-25475856;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NSK0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NSK0-2; Sequence=VSP_037875, VSP_037876;
CC       Name=3;
CC         IsoId=Q9NSK0-3; Sequence=VSP_038083;
CC       Name=4;
CC         IsoId=Q9NSK0-4; Sequence=VSP_043324, VSP_043325;
CC       Name=5;
CC         IsoId=Q9NSK0-5; Sequence=VSP_057231;
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the kinesin light chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC86788.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK055293; BAG51496.1; -; mRNA.
DR   EMBL; AK056393; BAG51695.1; -; mRNA.
DR   EMBL; AK094102; BAG52815.1; -; mRNA.
DR   EMBL; AK127018; BAC86788.1; ALT_SEQ; mRNA.
DR   EMBL; AK127894; BAC87179.1; -; mRNA.
DR   EMBL; AK297433; BAG59861.1; -; mRNA.
DR   EMBL; AL162078; CAB82411.1; -; mRNA.
DR   EMBL; AL136304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04149.1; -; Genomic_DNA.
DR   EMBL; BC012357; AAH12357.1; -; mRNA.
DR   EMBL; BC080637; AAH80637.1; -; mRNA.
DR   EMBL; BC103727; AAI03728.1; -; mRNA.
DR   EMBL; BX640717; CAE45836.1; -; mRNA.
DR   CCDS; CCDS47429.1; -. [Q9NSK0-4]
DR   CCDS; CCDS4882.1; -. [Q9NSK0-3]
DR   CCDS; CCDS4883.1; -. [Q9NSK0-1]
DR   CCDS; CCDS75459.1; -. [Q9NSK0-5]
DR   PIR; T47147; T47147.
DR   RefSeq; NP_001275963.1; NM_001289034.1. [Q9NSK0-1]
DR   RefSeq; NP_001275964.1; NM_001289035.1. [Q9NSK0-5]
DR   RefSeq; NP_612352.1; NM_138343.3. [Q9NSK0-4]
DR   RefSeq; NP_958929.1; NM_201521.2. [Q9NSK0-1]
DR   RefSeq; NP_958930.1; NM_201522.2. [Q9NSK0-1]
DR   RefSeq; NP_958931.1; NM_201523.2. [Q9NSK0-3]
DR   AlphaFoldDB; Q9NSK0; -.
DR   SMR; Q9NSK0; -.
DR   BioGRID; 124648; 110.
DR   IntAct; Q9NSK0; 64.
DR   MINT; Q9NSK0; -.
DR   STRING; 9606.ENSP00000259708; -.
DR   GlyGen; Q9NSK0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NSK0; -.
DR   PhosphoSitePlus; Q9NSK0; -.
DR   BioMuta; KLC4; -.
DR   DMDM; 116242607; -.
DR   EPD; Q9NSK0; -.
DR   jPOST; Q9NSK0; -.
DR   MassIVE; Q9NSK0; -.
DR   MaxQB; Q9NSK0; -.
DR   PaxDb; Q9NSK0; -.
DR   PeptideAtlas; Q9NSK0; -.
DR   PRIDE; Q9NSK0; -.
DR   ProteomicsDB; 4604; -.
DR   ProteomicsDB; 82562; -. [Q9NSK0-1]
DR   ProteomicsDB; 82563; -. [Q9NSK0-2]
DR   ProteomicsDB; 82564; -. [Q9NSK0-3]
DR   ProteomicsDB; 82565; -. [Q9NSK0-4]
DR   Antibodypedia; 30259; 77 antibodies from 18 providers.
DR   DNASU; 89953; -.
DR   Ensembl; ENST00000259708.7; ENSP00000259708.3; ENSG00000137171.15. [Q9NSK0-3]
DR   Ensembl; ENST00000347162.10; ENSP00000340221.5; ENSG00000137171.15. [Q9NSK0-1]
DR   Ensembl; ENST00000394056.6; ENSP00000377620.2; ENSG00000137171.15. [Q9NSK0-1]
DR   Ensembl; ENST00000453940.6; ENSP00000395806.2; ENSG00000137171.15. [Q9NSK0-5]
DR   Ensembl; ENST00000458460.6; ENSP00000410358.2; ENSG00000137171.15. [Q9NSK0-4]
DR   Ensembl; ENST00000467906.5; ENSP00000418759.1; ENSG00000137171.15. [Q9NSK0-2]
DR   Ensembl; ENST00000479388.5; ENSP00000418031.1; ENSG00000137171.15. [Q9NSK0-1]
DR   GeneID; 89953; -.
DR   KEGG; hsa:89953; -.
DR   MANE-Select; ENST00000347162.10; ENSP00000340221.5; NM_201521.3; NP_958929.1.
DR   UCSC; uc003otu.4; human. [Q9NSK0-1]
DR   CTD; 89953; -.
DR   DisGeNET; 89953; -.
DR   GeneCards; KLC4; -.
DR   HGNC; HGNC:21624; KLC4.
DR   HPA; ENSG00000137171; Tissue enhanced (liver).
DR   neXtProt; NX_Q9NSK0; -.
DR   OpenTargets; ENSG00000137171; -.
DR   PharmGKB; PA134934134; -.
DR   VEuPathDB; HostDB:ENSG00000137171; -.
DR   eggNOG; KOG1840; Eukaryota.
DR   GeneTree; ENSGT00940000161323; -.
DR   HOGENOM; CLU_1926883_0_0_1; -.
DR   InParanoid; Q9NSK0; -.
DR   OMA; LQHEGHE; -.
DR   OrthoDB; 511880at2759; -.
DR   PhylomeDB; Q9NSK0; -.
DR   TreeFam; TF314010; -.
DR   PathwayCommons; Q9NSK0; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SignaLink; Q9NSK0; -.
DR   BioGRID-ORCS; 89953; 20 hits in 1082 CRISPR screens.
DR   ChiTaRS; KLC4; human.
DR   GeneWiki; KLC4; -.
DR   GenomeRNAi; 89953; -.
DR   Pharos; Q9NSK0; Tdark.
DR   PRO; PR:Q9NSK0; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9NSK0; protein.
DR   Bgee; ENSG00000137171; Expressed in right lobe of liver and 168 other tissues.
DR   ExpressionAtlas; Q9NSK0; baseline and differential.
DR   Genevisible; Q9NSK0; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005871; C:kinesin complex; IEA:InterPro.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0019894; F:kinesin binding; IBA:GO_Central.
DR   GO; GO:0007018; P:microtubule-based movement; IBA:GO_Central.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR002151; Kinesin_light.
DR   InterPro; IPR015792; Kinesin_light_repeat.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   PRINTS; PR00381; KINESINLIGHT.
DR   SMART; SM00028; TPR; 5.
DR   SUPFAM; SSF48452; SSF48452; 2.
DR   PROSITE; PS01160; KINESIN_LIGHT; 3.
DR   PROSITE; PS50005; TPR; 6.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Microtubule; Motor protein; Phosphoprotein; Reference proteome; Repeat;
KW   TPR repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..619
FT                   /note="Kinesin light chain 4"
FT                   /id="PRO_0000215097"
FT   REPEAT          55..88
FT                   /note="TPR 1"
FT   REPEAT          211..244
FT                   /note="TPR 2"
FT   REPEAT          253..286
FT                   /note="TPR 3"
FT   REPEAT          295..328
FT                   /note="TPR 4"
FT   REPEAT          337..370
FT                   /note="TPR 5"
FT   REPEAT          379..412
FT                   /note="TPR 6"
FT   REPEAT          464..497
FT                   /note="TPR 7"
FT   REGION          154..201
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          510..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          598..619
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          32..150
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        154..177
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBS5"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07866"
FT   MOD_RES         565
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PQM2"
FT   MOD_RES         566
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         590
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         612
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         1
FT                   /note="M -> MEVTGFGVTRPGKVPQARM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038083"
FT   VAR_SEQ         87..163
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057231"
FT   VAR_SEQ         87..131
FT                   /note="VMLALASHLSTVESEKQKLRAQVRRLCQENQWLRDELAGTQQRLQ -> NLE
FT                   LRGCAHLGDAGSSQPPEHSGVGETEAAGSGAAAMPGEPVAAG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037875"
FT   VAR_SEQ         132..619
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037876"
FT   VAR_SEQ         295..315
FT                   /note="AATLNNLAVLYGKRGKYKEAE -> SIPCPPHPTPRTPHHCCFGLS (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043324"
FT   VAR_SEQ         316..619
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043325"
FT   VARIANT         72
FT                   /note="R -> H (in dbSNP:rs11558979)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_049708"
FT   CONFLICT        54
FT                   /note="L -> LQTIECL (in Ref. 1; BAC87179)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="T -> S (in Ref. 1; BAG51695)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        366
FT                   /note="I -> T (in Ref. 1; BAG51695)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434
FT                   /note="M -> L (in Ref. 1; BAG52815)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   619 AA;  68640 MW;  32DFC2A9A91B5574 CRC64;
     MSGLVLGQRD EPAGHRLSQE EILGSTRLVS QGLEALRSEH QAVLQSLSQT IECLQQGGHE
     EGLVHEKARQ LRRSMENIEL GLSEAQVMLA LASHLSTVES EKQKLRAQVR RLCQENQWLR
     DELAGTQQRL QRSEQAVAQL EEEKKHLEFL GQLRQYDEDG HTSEEKEGDA TKDSLDDLFP
     NEEEEDPSNG LSRGQGATAA QQGGYEIPAR LRTLHNLVIQ YAAQGRYEVA VPLCKQALED
     LERTSGRGHP DVATMLNILA LVYRDQNKYK EAAHLLNDAL SIRESTLGPD HPAVAATLNN
     LAVLYGKRGK YKEAEPLCQR ALEIREKVLG TNHPDVAKQL NNLALLCQNQ GKYEAVERYY
     QRALAIYEGQ LGPDNPNVAR TKNNLASCYL KQGKYAEAET LYKEILTRAH VQEFGSVDDD
     HKPIWMHAEE REEMSKSRHH EGGTPYAEYG GWYKACKVSS PTVNTTLRNL GALYRRQGKL
     EAAETLEECA LRSRRQGTDP ISQTKVAELL GESDGRRTSQ EGPGDSVKFE GGEDASVAVE
     WSGDGSGTLQ RSGSLGKIRD VLRRSSELLV RKLQGTEPRP SSSNMKRAAS LNYLNQPSAA
     PLQVSRGLSA STMDLSSSS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025